A New Dawn Against Superbugs: Personalized Phage Therapy Conquers Drug-Resistant Infections

MicrobiotiX Secures Landmark KRW 20 Billion Series B Funding, Catalyzing Korea's First-Ever Bacteriophage Clinical Trial to Combat Superbugs

The Silent Threat: Understanding Your Risk for the Deadly Candida Auris Fungus

Cracking the Superbug's Code: A Bistable Gene Offers Revolutionary Hope Against Antibiotic-Resistant Pseudomonas aeruginosa